Ribociclib
Novartis
['frida', 'kisqali', 'breast', 'novartis']
kisqali, a breast cancer pill made by novartis, reduced the risk of recurrence of the most common type of early breast cancer by 25% in a key trial, researchers said friday #asco23 via 
Chief, Early-Phase Drug Development|@SarahCannonDocs
#Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.